ABCB1 amplification drives paclitaxel resistance in PDAC cells, which can be targeted by novel drug combination strategies
This study investigate PDAC resistance to paclitaxel. Overall design: Comparative gene expression profiling analysis of RNA-seq data for Patu-T, Suit.2-028 and Patu-T and Suit.2-028 resistant to gemcitabine or paclitaxel cell lines